New Jersey

  • July 5, 2006

    Wachovia Forks Over $25M In Research Scandal

    Two years after a widespread crackdown on dishonest research analysts, Wachovia Capital Markets LLC has agreed to shell out $25 million to settle state regulators' charges of conflicts of interest between the company's research and investment banking operations.

  • June 30, 2006

    Johnson & Johnson Sues To Stop Generic Risperdal

    A subsidiary of Johnson & Johnson has filed a federal patent infringement lawsuit in an attempt to thwart a Canadian pharmaceutical company’s efforts to introduce a generic version of Risperdal, the latest in a series of suits filed by J&J to protect the market for its blockbuster antipsychotic drug.

  • June 29, 2006

    Court OKs Suit Alleging KPMG Failed To Detect Fraud

    In the latest blow to KPMG LLP, a court has greenlighted a lawsuit against the Big Four accounting firm brought by shareholders of a fraud-ridden company that lapsed into bankruptcy after KPMG, the company’s auditor, failed to perform proper audits.

  • June 28, 2006

    Diebold Faces Patent Suit In Voting Machine Spat

    Diebold Election Systems is facing a patent infringement battle with rival Avante International Technology Corp. over voting machines that gained notoriety in the last presidential campaign.

  • June 28, 2006

    Novartis, Mylan Spar Over Breast Cancer Treatment

    Drug makers Novartis Pharmaceuticals and Mylan Pharmaceuticals will meet in court over the patents for breast cancer treatment Femara, after an Abbreviated New Drug Application prompted Novartis to slap the generics maker with a lawsuit.

  • June 27, 2006

    Wall Street Swats “Fly” With Infringement Suit

    The brokerage units of three of the world’s largest securities firms—Merrill Lynch & Co., Morgan Stanley and Lehman Bros. Holdings Inc.—are taking Web site to court, alleging that the online provider of financial news is infringing on the firms’ proprietary equity research.

  • June 22, 2006

    Another Trial Set To Begin In Vioxx Fallout

    A trial has begun in California in one of a plethora of big-dollar lawsuits against pharmaceutical giant Merck & Co. over the company's former-blockbuster drug Vioxx.

  • June 22, 2006

    DOJ Alters Proposed Energy Merger

    The Justice Department may have driven two major Mid-Atlantic utilities to sell several plants by filing a suit Thursday that threatens to derail their $16 billion merger.

  • June 22, 2006

    Patent Suit Over Dermatology Drug Dismissed

    A federal court in Georgia thwarted an attempt by River’s Edge Pharmaceuticals LLC to move in on the market for Nicomide, dismissing a lawsuit that challenged the validity of the patent covering the drug, which treats inflammatory skin disorders.

  • June 22, 2006

    UnitedHealth Challenges AG’s Authority

    UnitedHealth Group is trying to stave off yet another lawsuit, challenging the investigation that the Minnesota Attorney General launched earlier this month into possible stock option grants and backdating.

  • June 19, 2006

    Home Depot Investigates Its Options Granting Practices

    Home Depot Inc. has joined the growing list of companies embroiled in questions about options practices, revealing that executives on three occasions were awarded options at below-market prices.

  • June 19, 2006

    St. Barnabas Shells Out $265M Over Medicare Fraud

    Saint Barnabas Health Care System has agreed to fork over $265 million to settle allegations that it defrauded Medicare out of more than half a billion dollars over an eight-year period.

  • June 16, 2006

    SEC Launches Three More Backdating Probes

    The flood of federal probes into options backdating continued this week, as three more companies received inquiries from the U.S. Securities and Exchange Commission.

  • June 14, 2006

    Mosaid, Infineon Settle Protracted Patent Litigation

    Memory chip companies Mosaid Technologies Inc. and Infineon Technologies AG settled two patent infringement lawsuits Wednesday, putting an end to an acrimonious battle fought for years in courtrooms on both coasts.

  • June 12, 2006

    NYSE Probes Possible Vonage Short-Selling

    Under fire from all sides, the Vonage Holdings Corp. initial public offering has come under attack by the New York Stock Exchange this week, with the agency's regulatory unit sending a letter to brokerage firms inquiring about possible short sales of Vonage shares.

  • June 12, 2006

    Fund Manager Settles Market-Timing Probe For $40M

    In the latest in New York State Attorney General Eliot Spizter’s probe into violations in the mutual fund industry, fund manager Fred Alger Management Inc. has agreed to shell out some $40 million to settle allegations it allowed illegal trading of its mutual fund shares.

  • June 8, 2006

    ITC To Investigate Sanofi Over Insulin Delivery Patent

    The International Trade Commission plans to investigate whether drug maker Sanofi-Aventis violated patent laws in what has turned into a bittersweet struggle over an insulin delivery system patent between the French company and Danish drug maker Novo Nordisk A/S.

  • June 8, 2006

    Emergency Motion Filed To Stop Icahn Deposition

    Attorneys for billionaire and majority shareholder Carl Icahn’s are seeking a protective order that would thwart efforts by the unsecured creditors committee of bankrupt gaming company GB Holdings Inc. to have Icahn and three other individuals deposed in the company’s Chapter 11 proceedings.

  • June 7, 2006

    Minnesota May File Suit Against UnitedHealth

    The legal onslaught caused by allegations of options backdating is just beginning for healthcare provider UnitedHealth Group. After being hit with several class action suits and a U.S. Securities and Exchange Commission investigation, the company may now face charges by the state of Minnesota.

  • June 6, 2006

    CalPERS Appeals NYSE’s Removal From Suit

    The California Public Employee’s Retirement System has appealed a decision that removed the New York Stock Exchange as a defendant in a lawsuit alleging that the exchange aided several investment banks in executing fraudulent trading schemes.